← Back to list

First Trust NYSE Arca Biotechnology UCITS ETF Acc

NYSE Arca Biotechnology

Equities
ISIN
IE00BL0L0H60
Issuer
First Trust
TER
0.60%
Latest closing price
N/A
Fund Size
€13 m As of: Sep 30, 2026
Domicile
Ireland
Distribution Policy
Accumulating
Replication Method
Physical
Base Currency
USD
WKN / Ticker
A2PZBP / FBTU

Data availability

Data is available for 2 of 5 areas for this fund.

  • Master data (TER, index, size): As of: Sep 30, 2026
  • Closing price: not available
  • Price history (at least 20 prices): not available
  • Holdings: As of: Jul 31, 2026
  • Risk figures: not available

Missing information is marked as “not available” and is not estimated. The issuer’s documents are authoritative.

At a glance

First Trust NYSE Arca Biotechnology UCITS ETF Acc (ISIN IE00BL0L0H60) is a fund from First Trust (fund type: ETF). Benchmark index: NYSE Arca Biotechnology. Its ongoing charges (TER) are 0.60% per year. The fund size is €13 m. Distribution policy: Accumulating. Replication: Physical. Fund domicile: Ireland.

Key Facts
  • Launch date 27.05.2020 (6 years)
  • Number of Holdings 30
  • Strategy Passive (index tracking)
  • Base Currency USD
  • Currency hedging No
  • Distribution Policy Accumulating
  • Replication Method Physical
  • Securities lending No
  • Domicile IE
  • UCITS Compliant Yes

Price development

Error loading comparison.
There is not enough price data available for this period yet.

Pure price change based on stored closing prices; distributions, purchase costs and taxes are not included. Different currencies and index types (price or total return index) can distort the comparison line. Past performance is not a reliable indicator of future results.

Risk figures (12 months)

No calculated risk figures are available for this fund yet.

The official summary risk indicator (SRI, scale 1–7) is in the issuer’s key information document (KID). The figures here are historical values and do not replace it.

Documents

We have no documents stored for this fund. The key information document (KID), factsheet and prospectus are provided by the issuer.

Tracking difference and tracking error

We have no comparison series stored for this fund’s index, so a tracking analysis is not possible.

What does the fund invest in?
As of 31.07.2026 · Source: justETF / etfdb
Sector Breakdown
  • Health care 99.9%
  • Other 0.1%
Country Breakdown
  • United States 83.1%
  • Switzerland 3.6%
  • Denmark 3.4%
  • Germany 3.4%
  • Netherlands 3.3%
  • Ireland 3.2%
  • Other 0.1%

Holdings

Showing 10 holdings that together make up 36.7 % of fund assets. (out of 30 holdings in total).

# Name ISIN Sector Country Weight
1 Corcept Therapeutics US2183521028 – – 4.22 %
2 Regeneron Pharmaceuticals, Inc. US75886F1075 – – 3.89 %
3 Halozyme Therapeutics US40637H1095 – – 3.67 %
4 NeoGenomics US64049M2098 – – 3.67 %
5 Illumina, Inc. US4523271090 – – 3.65 %
6 Amgen, Inc. US0311621009 – – 3.59 %
7 BeOne Medicines US07725L1026 – – 3.58 %
8 Bruker US1167941087 – – 3.54 %
9 Incyte Corp. US45337C1027 – – 3.47 %
10 Biogen US09062X1037 – – 3.45 %
Cost calculator
What does this ETF cost you per year – and over your whole investment horizon?
Cost in year 1
–
Total cost impact
–

Simplified model based on the TER, excluding order fees, spreads, taxes and tracking difference. Not investment advice.

Alternatives on the same index
Other ETFs tracking the NYSE Arca Biotechnology – cheapest first.
We know of no other ETFs tracking exactly this index.

Frequently asked questions about the First Trust NYSE Arca Biotechnology UCITS ETF Acc

The total expense ratio (TER) of the First Trust NYSE Arca Biotechnology UCITS ETF Acc is 0.60% per year. The costs are deducted from the fund assets on an ongoing basis and are already reflected in its performance.

The First Trust NYSE Arca Biotechnology UCITS ETF Acc tracks the NYSE Arca Biotechnology. Our index encyclopedia explains the index and lists all funds that track it.

The First Trust NYSE Arca Biotechnology UCITS ETF Acc is accumulating: income such as dividends is not paid out but automatically reinvested in the fund.

The First Trust NYSE Arca Biotechnology UCITS ETF Acc uses physical replication: it holds the securities of the index directly – either in full or as a representative sample (sampling).

The fund size of the First Trust NYSE Arca Biotechnology UCITS ETF Acc is €13 m. A large fund size usually indicates good tradability and a lower risk of the fund being closed.

The First Trust NYSE Arca Biotechnology UCITS ETF Acc is domiciled in Ireland. The fund domicile affects, among other things, how withholding taxes are treated inside the fund.

The provider (issuer) of the First Trust NYSE Arca Biotechnology UCITS ETF Acc is First Trust.

All information without guarantee. It is provided for information purposes only and does not constitute investment advice.